Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.345 AUD | -1.43% | +2.99% | +68.29% |
05-01 | Dimerix Secures Pediatric Plan Approval in the UK for Kidney Disease Medication | MT |
04-22 | Dimerix Posts AU$35.2 Million Cash, AU$3.3 Million Operating Cash Outflows for March Quarter | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+68.29% | 127M | |
+22.81% | 46.81B | |
+47.13% | 41.29B | |
-1.88% | 41.37B | |
-6.20% | 28.87B | |
+11.33% | 26.06B | |
-21.00% | 19.13B | |
-1.43% | 11.96B | |
+30.73% | 12.39B | |
-0.48% | 12.08B |
- Stock Market
- Equities
- DXB Stock
- News Dimerix Limited
- Dimerix Doses First Patients in Phase 3 Study of COVID-19 Respiratory Complications Drug; Shares Rise 6%